Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) [Phase 2]
A Phase 2 clinical trial to evaluate the long-term safety, tolerability, and efficacy of Balinatunfib in participants with Crohn's disease o…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: LATA-IBD TRIAL a Controlled Feasibility Study for the Introduction of Transanal Minimally Invasive IPAA-Surgery. Evaluation of Operative Results and Bowel Function After Introducing Transanal IPAA-surgery to Replace Conventional Laparoscopic IPAA-surgery.
This completed clinical trial evaluates operative results and bowel function after introducing transanal minimally invasive IPAA surgery as …
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis [NA]
This clinical trial update reports on the ongoing evaluation of etrasimod for ulcerative colitis in elderly patients; the study is currently…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
A completed study evaluating VedAryo (vedolizumab) for effectiveness and safety in ulcerative colitis and Crohn's disease. The update report…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: The Nordic IBD Treatment Strategy Trial [Phase 4]
The Nordic IBD Treatment Strategy Trial has completed Phase 4.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
This is a clinical trial update about a robotic system for inflammatory bowel disease development, learning, and efficacy, which is currentl…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating guselkumab for moderately to severely active ulcerative colitis, not…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating guselkumab for moderately to severely active ulcerative colitis is active/not recruiting with results posted.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Effects of Pomegranate Juice on Ulcerative Colitis [NA]
A UCLA-sponsored clinical trial is evaluating the effects of pomegranate juice on ulcerative colitis. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
An observational study evaluating etrasimod in adults with moderate to severe ulcerative colitis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
A Phase 2 trial evaluating TEV-48574 for moderate-to-severe ulcerative colitis or Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an oral capsule fecal microbiota transplant (FMT) in treatment-naïve patients with newly…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The Association Between TNFSF4 Polymorphism and CD
A completed clinical trial evaluating the association between TNFSF4 polymorphisms and inflammatory bowel diseases, specifically Crohn's dis…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis. [NA]
An exploratory clinical trial is evaluating the safety and efficacy of sacral nerve stimulation for ulcerative colitis and is currently recr…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
This clinical trial real-world study is assessing the long-term effectiveness and safety of fecal microbiota transplantation across several …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
A clinical trial update describes a study of ozanimod in pregnant women with ulcerative colitis and their offspring; the study status is not…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis
A completed clinical trial assessing how a therapeutic intervention impacts quality of life in patients with ulcerative colitis.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]
This clinical trial entry describes a long-term extension study of vedolizumab in children and teenagers with ulcerative colitis or Crohn's …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD [NA]
A clinical trial update indicates a study evaluating hyperbaric oxygen-assisted treatment for acute severe ulcerative colitis and refractory…
-
FDA approval · 2025-12-01FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for SELARSDI (USTEKINUMAB-AEKN), a biosimilar to ustekinumab.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis [NA]
A clinical trial sponsored by Mayo Clinic is recruiting to evaluate endoscopic sleeve gastroplasty for obesity in patients with ulcerative c…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis [Phase 2]
A dose-ranging Phase 2b study of ABX464 in moderate to severe ulcerative colitis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
This clinical trial update describes an observational study evaluating the effectiveness and safety of Upadacitinib in Chinese adults with m…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating Bertilimumab for active moderate to severe ulcerative colitis has been terminated with results posted.